Back
Marker Therapeutics Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
33
MRKR
Marker Therapeutics
Last Price:
3.50
Seasonality Move:
8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Marker Therapeutics Price Quote
$3.50
-0.14 (-3.85%)
(Updated: November 14, 2024 at 5:35 PM ET)
Marker Therapeutics Key Stats
Sell
33
Marker Therapeutics (MRKR)
is a Sell
Day range:
$3.60 - $3.90
52-week range:
$2.44 - $6.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.42%
Volume:
23.1K
Avg. volume:
44K
1-year change:
37.88%
Market cap:
$33.2M
Revenue:
$0
EPS:
$-1.18
How Much Does Marker Therapeutics Make?
Data Unavailable
Is Marker Therapeutics Growing As A Company?
Data Unavailable
Marker Therapeutics Stock Price Performance
-
Did Marker Therapeutics Stock Go Up Last Month?
Marker Therapeutics share price went up by 34.32% last month -
Did MRKR's Share Price Rise Over The Last Year?
MRKR share price rose by 37.88% over the past 1 year
What Is Marker Therapeutics 52-Week High & Low?
-
What Is Marker Therapeutics’s 52-Week High Share Price?
Marker Therapeutics has traded as high as $6.16 over the past 52 weeks -
What Is Marker Therapeutics’s 52-Week Low Share Price?
Marker Therapeutics has traded as low as $2.44 over the past 52 weeks
Marker Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Marker Therapeutics?
-
How Much Debt Does Marker Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Marker Therapeutics Have?
Cash and short term investments quarterly total is $7.8M -
What Is Marker Therapeutics’s Book Value Per Share?
Book value per share is 1.09
Is Marker Therapeutics Cash Flow Positive?
-
What Is MRKR Cash Flow From Operations?
Cash flow from operations (TTM) is -$10.9M -
What Is Marker Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $578.1K -
What Is Marker Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Marker Therapeutics Return On Invested Capital
Data Unavailable
Marker Therapeutics Earnings Date & Stock Price
-
What Is Marker Therapeutics's Stock Price Today?
A single share of MRKR can be purchased today for 3.64 -
What Is Marker Therapeutics’s Stock Symbol?
Marker Therapeutics trades on the nasdaq under the ticker symbol: MRKR -
When Is Marker Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Marker Therapeutics is scheduled on November 15, 2024 -
When Is MRKR's next ex-dividend date?
Marker Therapeutics's next ex-dividend date is November 14, 2024 -
How To Buy Marker Therapeutics Stock?
You can buy Marker Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Marker Therapeutics Competitors
-
Who Are Marker Therapeutics's Competitors?
Below is a list of companies who compete with Marker Therapeutics or are related in some way:
Marker Therapeutics Dividend Yield
-
What Is MRKR Dividend Yield?
Marker Therapeutics’s dividend yield currently is 0% -
What Is Marker Therapeutics’s Payout Ratio?
Marker Therapeutics’s payout ratio is 0% -
When Did Marker Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Marker Therapeutics’s Dividend Per Share?
Marker Therapeutics pays a dividend of $0.00 per share
Marker Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 41.86% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 19.00 |
| Upside from Last Price: | 421.98% |